Altimmune Inc. (ALT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Altimmune Inc.

    NASDAQ: ALT · Real-Time Price · USD
    3.64
    -0.05 (-1.36%)
    At close: Sep 12, 2025, 3:59 PM
    3.65
    0.27%
    After-hours: Sep 12, 2025, 07:55 PM EDT

    Altimmune Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 20K 426K -68K 4.41M
    Cost of Revenue
    		 n/a 477K 500K 73.84M
    Gross Profit
    		 20K -51K -568K -69.43M
    Operating Income
    		 -103.17M -95.93M -87.74M -96.91M
    Interest Income
    		 8.07M 7.35M 2.87M 203K
    Pretax Income
    		 -95.06M -88.45M -84.91M -97.09M
    Net Income
    		 -95.06M -88.45M -84.71M -97.09M
    Selling & General & Admin
    		 20.97M 18.14M 17.13M 15.41M
    Research & Development
    		 82.23M 65.8M 70.54M 74.54M
    Other Expenses
    		 n/a -53.38M -70.45M -62.47M
    Operating Expenses
    		 103.19M 30.56M 17.22M 27.48M
    Interest Expense
    		 9K 35K 8K 5K
    Selling & Marketing Expenses
    		 n/a n/a n/a 282.00
    Cost & Expenses
    		 103.19M 96.36M 87.67M 101.32M
    Income Tax Expense
    		 n/a n/a -197K -919.51K
    Shares Outstanding (Basic)
    		 71M 53.25M 46.93M 41.28M
    Shares Outstanding (Diluted)
    		 71M 53.25M 46.93M 41.28M
    EPS (Basic)
    		 -1.34 -1.66 -1.81 -2.35
    EPS (Diluted)
    		 -1.34 -1.66 -1.81 -2.35
    EBITDA
    		 -94.81M -87.94M -84.4M -96.53M
    EBIT
    		 -95.05M -88.41M -84.9M -97.08M
    Depreciation & Amortization
    		 238K 477K 500K 551K

    Add to Watchlist